Skip to main content Accessibility help
×
Home
  • Print publication year: 2020
  • Online publication date: June 2020

Chapter 4 - Premature Ovarian Insufficiency

Summary

Although in vitro fertilization (IVF) was developed for the treatment of tubal infertility, [1], it soon became apparent that human IVF had many other applications such as male factor subfertility [2], unexplained subfertility [3] and restoring fertility in women without functioning ovaries using ovum [4] or embryo donation. Although ovum donation was originally used to treat women with Turner’s syndrome [5], it has also been successfully applied to women with other causes of premature ovarian insufficiency (POI) over the last 35 years. The concept of gamete donation is not new, with sperm donation (DI) having been utilized, initially with fresh sperm and subsequently with stored frozen sperm for several decades [6]. In DI the woman’s partner becomes the social father but is not the genetic father, whereas in oocyte donation the woman who has the child is the birth and social mother, but not the genetic mother. Although the child is not directly genetically linked, egg donation allows the patient to carry and deliver her husband’s genetic child.

1.Steptoe, PC, Edwards, RG. Birth after the reimplantation of a human embryo. Lancet 1978 Aug 12;2(8085):366.
2.deKretser, DM, Yates, C, Kovacs, GT. The use of in vitro fertilization in the management of male infertility. Clin Obstet Gynecol 1986;12:767–73.
3.Trounson, AO, Leeton, JF, Wood, C, Kovacs, GT. The investigation of idiopathic infertility by in vitro fertilization. Fertil Steril 1980;34:431–8.
4.King, CM, Kovacs, GT. Oocyte donation: review of results. Reprod Fertil Develop 1992;4:719–24.
5.Trounson, A, Leeton, J, Besanko, M, Wood, C, Conti, A. Pregnancy established in an infertile patient after transfer of a donated embryo fertilised in vitro. Br Med J (Clin Res Ed) 1983;286(6368):835–8.
6.Kovacs, GT, Lording, DW. Artificial insemination with donor semen – a review of 252 patients. Med J Aust 1980;2:609–11.
7.Conradt, E, Adkins, DE, Crowell, SE, Raby, KL, Diamond, LM, Ellis, B. Incorporating epigenetic mechanisms to advance fetal programming theories. Dev Psychopathol 2018;30(3):807–24.
8.Ferraretti, AP, Goossens, V, de Mouzon, J, Bhattacharya, S, Castilla, JA, Korsak, V, Kupka, M, Nygren, KG, Nyboe, Andersen A, European IVF-Monitoring (EIM), Consortium for European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 2012;27(9):2571–84.
9.De Geyter, C, Calhaz-Jorge, C, Kupka, MS, Wyns, C, Mocanu, E, Motrenko, T, Scaravelli, G, Smeenk, J, Vidakovic, S, Goossens, V. The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) ART in Europe, 2014: results generated from European registries by ESHRE. Hum Reprod 2018;33(9):15861601.
11.Wood, C, Downing, B, Trounson, A, Rogers, P. Clinical implications of developments in in vitro fertilisation. Br Med J (Clin Res Ed) 1984 Oct 13;289(6450):978–80.
12.Sung, L, Bustillo, M, Mukherjee, T, Booth, G, Karstaedt, A, Copperman, AB. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997;67(5):912–16.
13.Rodino, IS, Burton, PJ, Sanders, KA. Donor information considered important to donors, recipients and offspring: an Australian perspective. Reprod BioMed Online 2011;22:303–11.
14.Kupka, MS, Ferraretti, AP, de Mouzon, J, Erb, K, D’Hooghe, T, Castilla, JA, Calhaz-Jorge, C, De Geyter, C, Goossens, V, European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE the European IVF-monitoring (EIM), Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2014;29(10):2099–113.
15.Ahuja, KK, Simons, EG, Fiamanya, W. Egg sharing in assisted conception: ethical and practical considerations. Human Reprod 1996;11:1126–31.
16.Oyesanya, OA, Olufowobi, O, Ross, W, Sharif, K, Afnan, M. Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization – embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors. Fertil Steril 2009;92(3):930–6.
17.Ahuja, KK, Simons, EG, Mostyn, BJ, Bowen-Simpkins, P. An assessment of the motives and morals of egg share donors: policy of ‘payments’ to egg donors requires a fair review. Hum Reprod 1998;13(10):2671–8.
18.Kovacs, G. Oocyte collection. In: Gardner, DK, Weissman, A, Howles, CM, Shoham, Z, eds., Textbook of Reproductive Technologies, 5th ed. 2018. CRC Press pp. 594601.
19.Ethics Committee of the American Society for Reproductive Medicine. Financial compensation for ovum donors. Fertil Steril 2007;88(2):305–9.
20.Keehn, J, Holwell, E, Abdul-Karim, R, Chin, LJ, Leu, CS, Sauer, MV, Klitzman, R. Recruiting egg donors online: an analysis of in vitro fertilization clinics and agency websites’ adherence to American Society for Reproductive Medicine guidelines. Fertil Steril 2012;98(4):19952000.
23.Seem, DL, Lee, I, Umscheid, CA, Kuehnert, MJ, United States Public Health Service. PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission through Organ Transplantation. Public Health Rep 2013;128:247304.
24.Shenfield, F, de Mouzon, J, Pennings, G, Ferraretti, AP, Andersen, AN, de Wert, G, Goossens, V, ESHRE Taskforce on Cross Border Reproductive Care. Cross border reproductive care in six European countries. Hum Reprod 2010;25:1361–8.
26.Gutarra-Vilchez, RB, Bonfill Cosp, X, Glujovsky, D, Urrútia, G. Vasodilators for women undergoing assisted reproduction. Cochrane Database Syst Rev 2012;7:CD010001.
27.Bhattacharya, S, Hamilton, MP, Shaaban, M, Khalaf, Y, Seddler, M, Ghobara, T, Braude, P, Kennedy, R, Rutherford, A, Hartshorne, G, Templeton, A. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non male factor infertility: a randomised controlled trial. Lancet 2001;357(9274):2075–99.
28.Fitzgerald, O, Paul, RC, Harris, K, Chambers, GM. Assisted Reproductive Technology in Australia and New Zealand 2016. 2018. National Perinatal Epidemiology and Statistics Unit, University of New South Wales Sydney.
29.Budak, E, Garrido, N, Soares, SR, Melo, MA, Meseguer, M, Pellicer, A, Remohí, J. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil Steril 2007;88(2):342–9.
30.Roberts, SA, McGowan, L, Hirst, WM, Vail, A, Rutherford, A, Lieberman, BA, Brison, DR. Reducing the incidence of twins from IVF treatments: predictive modelling from a retrospective cohort. Hum Reprod 2011;26(3):569–75.
31.NICE Guidelines 2013.
32.Woods, DC, Tilly, JL. Isolation, characterization and propagation of mitotically active germ cells from adult mouse and human ovaries. Nat Protocol 2013 May;8(5):966–88.
33.Gura, T. Reproductive biology: fertile mind. Nature 2012;491:318–20.
34.Grieve, KM, McLaughlin, M, Dunlop, CE, Telfer, EE, Anderson, RA. The controversial existence and functional potential of oogonial stem cells. Maturitas 2015;82(3):278–81.